Neurogenic orthostatic hypotension: A double-blind, placebo-controlled study with midodrine

Thomas, 1970, Idiopathic onthostatic hypotension: a study of its natural history in 57 neurologically affected patients, Arch Neurol, 22, 289, 10.1001/archneur.1970.00480220003001 Schirger, 1981, Midodrine: a new agent in the management of idiopathic orthostatic hypotension and Shy-Drager syndrome, Mayo Clin Proc, 56, 429 Ahmed, 1990, Treatment of postural hypotension: a review, Drugs, 39, 74, 10.2165/00003495-199039010-00007 Chobanian, 1979, Mineralocorticoid-induced hypotension in patients with orthostatic hypotension, N Engl J Med, 301, 68, 10.1056/NEJM197907123010202 Polinsky, 1983, Pharmacological responses and biochemical changes in progressive autonomic failure, 221 Chobanian, 1983, Treatment of chronic orthostatic hypotension with ergotamine, Circulation, 67, 602, 10.1161/01.CIR.67.3.602 Jennings, 1979, Treatment of orthostatic hypotension with dihydroergotamine, BMJ, 279, 307, 10.1136/bmj.2.6185.307 Fouad, 1981, Dihydroergotamine in idiopathic orthostatic hypotension: short-term intramuscular and long-term oral therapy, Clin Pharmacol Ther, 30, 782, 10.1038/clpt.1981.238 Diamond, 1970, Idiopathic postural hypotension: physiological observations and reports of a new mode of therapy, J Clin Invest, 40, 1341, 10.1172/JCI106350 Kochar, 1978, Treatment of idiopathic orthostatic hypotension (Shy-Drager syndrome) with indomethacin, Lancet, 1, 1011, 10.1016/S0140-6736(78)90737-7 Polinsky, 1981, Effect of indomethacin inhibition of prostaglandin synthesis on blood pressure and plasma norepinephrine levels in patients with orthostatic hypotension, Neurology, 31, 63 Kuchel, 1980, Treatment of severe orthostatic hypotension by metoclopropamide, Ann Intern Med, 93, 841, 10.7326/0003-4819-93-6-841 Robertson, 1983, Clonidine raises blood pressure in idiopathic orthostatic hypotension, Am J Med, 74, 193, 10.1016/0002-9343(83)90607-1 Moss, 1980, Atrial tachypacing in the treatment of a patient with primary orthostatic hypotension, N Engl J Med, 302, 1456, 10.1056/NEJM198006263022606 Davies, 1978, Pressor amines and monoamine-oxidase inhibitors for treatment of postural hypotension in autonomic failure, 1, 172 Schatz, 1984, Orthostatic hypotension: II. Clinical diagnosis, testing, and treatment, Arch Intern Med, 144, 1037, 10.1001/archinte.1984.00350170203031 Thulesius, 1979, Vasoconstrictor effect of midodrine, ST 1059, noradrenaline, etilefrine and dihydroergotamine on isolated human veins, Eur J Clin Pharmacol, 16, 423, 10.1007/BF00568204 Yamazaki, 1988, Effects of a-adrenoceptor agonists on cardiac output and blood pressure in spinally anesthetized ganglion-blocked dogs, Arch Int Pharmacodyn Ther, 295, 80 Pittner, 1976, Pharmacodynamic actions of midodrine, a new alpha-adrenergic stimulating agent, and its main metabolite, ST 1059, Arzneimittelforschung, 26, 2145 Zachariah, 1986, Pharmacodynamics of midodrine, an antihypotensive agent, Clin Pharmacol Ther, 39, 586, 10.1038/clpt.1986.101 Bannister, 1988, Clinical features of autonomic failure, 267 Polinsky, 1981, Pharmacologic distinction of different orthostatic hypotension syndromes, Neurology, 31, 1, 10.1212/WNL.31.1.1 Lachner, 1974, Pharmakologie von midodrin sowie dessen klinsche austestung bei hypotoner regulationsstorung des kreislaufes, Wien Klin Wochenschr, 86, 344 Kratz, 1975, Behandlung hypotoner kreislaufdysregulationen in der praxis mit Gutron®, Wien Med Wochenschr, 125, 189 Kratz, 1978, Klinische vergleichsstudie einer antihypotensiven therapie mit Gutron® and einem depot-praparat, DR. Med Mabuse, 7, 36 Zeigler, 1977, The sympathetic nervous system in primary orthostatic hypotension, N Engl J Med, 296, 293, 10.1056/NEJM197702102960601 Stacy, 1992, Differential diagnosis of Parkinson's disease and the parkinsonism plus syndromes, Neurol Clin, 10, 341, 10.1016/S0733-8619(18)30214-7 Polinsky, 1984, Multiple system atrophy: clinical aspects, pathophysiology and treatment, 2, 487 Coghlan, 1988, Autonomic dysfunction in the mitral valve prolapse syndrome: the brain-heart connection and interaction, 389 Bannister, 1988, Introduction and classification, 1 Kuehner, 1990, Standing up to orthostatic hypotension, Can J Diagnosis, 81 Mader, 1989, Orthostatic hypotension, Med Clin North Am, 73, 1337, 10.1016/S0025-7125(16)30602-2 Robertson, 1985, Orthostatic hypotension-diagnosis and therapy, Modern Concepts of Cardiovascular Disease, 54, 7 Polinsky, 1987, Orthostatic hypotension, 316 Onrot, 1986, Management of chronic orthostatic hypotension, Am J Med, 80, 454, 10.1016/0002-9343(86)90720-5 Bankhead, 1990, Finding the cause [of] syncope, Medical World News, 28 Levene, 1960, Robust tests for equality of variance, 278 McTavish, 1989, Midodrine: a review of its pharmacological properties and therapeutic use in orthostatic hypotension and secondary hypotensive disorders, Drugs, 38, 757, 10.2165/00003495-198938050-00004 Kaufmann, 1988, Treatment of orthostatic hypotension due to autonomic failure with a peripheral alpha-adrenergic agonist (midodrine), Neurology, 38, 951, 10.1212/WNL.38.6.951 Marini, 1984, Controlled clinical investigation of dimetophrine versus midodrine in the management of moderately decreased arterial blood pressure, Curr Med Res Opin, 9, 265, 10.1185/03007998409109590 Petersen-Clonan, 1986, A compassionate use study of midodrine in the treatment of patients with orthostatic hypotension, J Clin Pharmacol, 26, 543 Vukovich, 1989, Correction of severe orthostatic hypotension by midodrine, a new alpha adrenoceptor agonist, Clin Pharmacol Ther, 45, 123 Hines, 1981, The clinical spectrum of autonomic dysfunction, Am J Med, 70, 1091, 10.1016/0002-9343(81)90878-0 Ehringer, 1971, Untersuchungen der peripheren hamodynamik des menschen nach intravenoser infusion einer kleinen dosis von dl-(2′-5′-dimethyloxyphenyl)-2-glycinamidoathanol-(1)-hydrochlorid (=ST 1085), Internationale Zeitschrift fuer Klinische Pharmakologie, Therapie, and Toxicologie, 4, 415 Streeten, 1988, Abnormal orthostatic changes in blood pressure and heart rate in subjects with intact sympathetic nervous function: evidence for excessive venous pooling, J Lab Clin Med, 111, 326 Hitzenberger, 1973, Hamodynamische wirkungen einer neuen blutdrucksteigernden substanz (2′,5′-dimethoxyphenyl- 2-glycinami-doathonal-1-hydrochlorid) nach intravenoser verabreichung, Int J Clin Pharmacol Res, 7, 323 1987, 1, 197 Thulesius, 1976, Pathophysiological classification and diagnosis of orthostatic hypotension, Cardiology, 61, 180, 10.1159/000169809 Mader, 1987, Low prevalence of postural hypotension among community-dwelling elderly, JAMA, 258, 1511, 10.1001/jama.1987.03400110093033 Bannister, 1988, Management of postural hypotension, 569